Search results
Why Pfizer Stock Blasted More Than 6% Higher Today
Motley Fool via Yahoo Finance· 9 hours agoWhile this was 20% below its...vaccine and Paxlovid, a drug). Removing such goods from the equation, Pfizer would have enjoyed 11% year-over-year revenue...
Pfizer (PFE) Q1 2024 Earnings Call Transcript
Motley Fool via Yahoo Finance· 9 hours agoThrough the first three months of the year, we reached more than 119 million patients with our medicines and vaccines. We will continue to build on ...
Pfizer Inc (PFE) Q1 2024 Earnings: Adjusted EPS Surpasses Expectations Amidst Revenue Decline
GuruFocus.com via Yahoo Finance· 17 hours agoNotable increases were also seen in the Vyndaqel family and Eliquis revenues, driven by market...
Pfizer Reportedly Plans D2C COVID and Migraine Drug Platform
PYMNTS.com· 15 hours agoPharmaceutical giant Pfizer is reportedly creating an online platform selling anti-COVID and...
Pfizer hemophilia gene therapy arrives in US to uncertain future
BioPharma Dive via Yahoo Finance· 6 days agoBoth were seen as would-be...three months of 2024, causing BioMarin to weigh divesting the drug...
Pfizer’s 44% Decline In Profits Still Tops Estimates—Stock Bounces From Decade Low
Forbes· 1 day agoPfizer comfortably beat expectations in its quarterly earnings report Wednesday morning, as the...
Earnings call: Pfizer raises 2024 EPS outlook despite revenue decline By Investing.com
Investing.com· 10 hours agoPfizer Inc. (NYSE:PFE) reported its first-quarter financial results for 2024, indicating a solid...
Pfizer lifts profit view on cost cuts, demand for COVID products
Reuters· 13 hours agoSales of Padcev, a treatment for advanced bladder cancer Pfizer gained through its $43 billion deal...
Stock market today: gloomy start to May ahead of Fed decision
Newsweek· 20 hours agoU.S. futures were down Wednesday morning ahead of a decision by the Federal Reserve on interest...
Novartis Is Tracking Well Above the Industry
GuruFocus.com via Yahoo Finance· 17 hours agoThe Swiss pharmaceutical company is expected to release second-quarter financial results on July 18. Analysts forecast Novartis' revenue..., this...
